FdaApplication

NDA 020548

Back to search

Identifiers

Properties

PropertyValue
applicant_nameGLAXOSMITHKLINE
application_typeNDA
approval_date1996-03-27

Products (3)

ProductActive ingredientStrengthDosage form
FLOVENTFLUTICASONE PROPIONATE0.044MG/INHAEROSOL, METERED;INHALATION
FLOVENTFLUTICASONE PROPIONATE0.11MG/INHAEROSOL, METERED;INHALATION
FLOVENTFLUTICASONE PROPIONATE0.22MG/INHAEROSOL, METERED;INHALATION

3 products